Structure

Physi-Chem Properties

Molecular Weight:  580.18
Volume:  543.294
LogP:  0.735
LogD:  0.425
LogS:  -1.639
# Rotatable Bonds:  11
TPSA:  210.9
# H-Bond Aceptor:  14
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.114
Synthetic Accessibility Score:  4.889
Fsp3:  0.481
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.29
MDCK Permeability:  8.482298289891332e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.557
Human Intestinal Absorption (HIA):  0.867
20% Bioavailability (F20%):  0.125
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.269
Plasma Protein Binding (PPB):  45.038360595703125%
Volume Distribution (VD):  0.411
Pgp-substrate:  25.26434326171875%

ADMET: Metabolism

CYP1A2-inhibitor:  0.032
CYP1A2-substrate:  0.071
CYP2C19-inhibitor:  0.026
CYP2C19-substrate:  0.108
CYP2C9-inhibitor:  0.016
CYP2C9-substrate:  0.066
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.135
CYP3A4-inhibitor:  0.083
CYP3A4-substrate:  0.182

ADMET: Excretion

Clearance (CL):  2.828
Half-life (T1/2):  0.955

ADMET: Toxicity

hERG Blockers:  0.019
Human Hepatotoxicity (H-HT):  0.189
Drug-inuced Liver Injury (DILI):  0.954
AMES Toxicity:  0.193
Rat Oral Acute Toxicity:  0.496
Maximum Recommended Daily Dose:  0.094
Skin Sensitization:  0.349
Carcinogencity:  0.728
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.942

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC203664

Natural Product ID:  NPC203664
Common Name*:   E-6-O-P-Feruloyl Scandoside Methyl Ester
IUPAC Name:   methyl (1S,4aS,5R,7aS)-5-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate
Synonyms:  
Standard InCHIKey:  QHRICBJWYCXFDR-GZJXMKRRSA-N
Standard InCHI:  InChI=1S/C27H32O14/c1-36-16-7-12(3-5-15(16)30)4-6-19(31)39-17-8-13(9-28)20-21(17)14(25(35)37-2)11-38-26(20)41-27-24(34)23(33)22(32)18(10-29)40-27/h3-8,11,17-18,20-24,26-30,32-34H,9-10H2,1-2H3/b6-4+/t17-,18-,20-,21+,22-,23+,24-,26+,27+/m1/s1
SMILES:  COc1cc(ccc1O)/C=C/C(=O)O[C@@H]1C=C(CO)[C@@H]2[C@H]1C(=CO[C@H]2O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)C(=O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL592955
PubChem CID:   46225505
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0004081] Iridoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32921 hedyotis diffusa Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[11170670]
NPO32921 hedyotis diffusa Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[20004577]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT279 Individual Protein Leukocyte elastase Homo sapiens Inhibition = 25.1 % PMID[501379]
NPT279 Individual Protein Leukocyte elastase Homo sapiens IC50 > 100000.0 nM PMID[501379]
NPT279 Individual Protein Leukocyte elastase Homo sapiens Inhibition = 23.6 % PMID[501379]
NPT279 Individual Protein Leukocyte elastase Homo sapiens Inhibition = 22.9 % PMID[501379]
NPT279 Individual Protein Leukocyte elastase Homo sapiens Inhibition = 23.3 % PMID[501379]
NPT279 Individual Protein Leukocyte elastase Homo sapiens Inhibition = 24.7 % PMID[501379]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC203664 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9375 High Similarity NPC475213
0.9375 High Similarity NPC152796
0.9342 High Similarity NPC179914
0.9324 High Similarity NPC69367
0.9216 High Similarity NPC469384
0.9161 High Similarity NPC476011
0.915 High Similarity NPC475663
0.915 High Similarity NPC286919
0.9133 High Similarity NPC269914
0.9133 High Similarity NPC478249
0.9128 High Similarity NPC478242
0.9097 High Similarity NPC220936
0.9097 High Similarity NPC31745
0.9032 High Similarity NPC474936
0.902 High Similarity NPC475484
0.8987 High Similarity NPC301910
0.8987 High Similarity NPC130730
0.8966 High Similarity NPC226005
0.8958 High Similarity NPC157554
0.894 High Similarity NPC147224
0.8933 High Similarity NPC308178
0.8924 High Similarity NPC180586
0.8919 High Similarity NPC110063
0.8912 High Similarity NPC296643
0.8903 High Similarity NPC226759
0.8889 High Similarity NPC245615
0.8889 High Similarity NPC61604
0.8889 High Similarity NPC299706
0.8889 High Similarity NPC478241
0.8889 High Similarity NPC89693
0.8889 High Similarity NPC229548
0.8889 High Similarity NPC115466
0.8875 High Similarity NPC21956
0.8867 High Similarity NPC473149
0.8859 High Similarity NPC287615
0.8859 High Similarity NPC83743
0.8859 High Similarity NPC262182
0.8859 High Similarity NPC216819
0.8851 High Similarity NPC293154
0.8846 High Similarity NPC76211
0.8836 High Similarity NPC100389
0.8831 High Similarity NPC327032
0.8831 High Similarity NPC191046
0.8831 High Similarity NPC194095
0.8797 High Similarity NPC206815
0.8792 High Similarity NPC202391
0.8792 High Similarity NPC296659
0.8792 High Similarity NPC297342
0.8784 High Similarity NPC140502
0.8784 High Similarity NPC157816
0.8776 High Similarity NPC202700
0.8774 High Similarity NPC38699
0.8766 High Similarity NPC44730
0.8758 High Similarity NPC475379
0.875 High Similarity NPC282551
0.8733 High Similarity NPC34587
0.8733 High Similarity NPC100998
0.8733 High Similarity NPC34927
0.8733 High Similarity NPC476382
0.8733 High Similarity NPC252292
0.8725 High Similarity NPC478239
0.8718 High Similarity NPC163635
0.8718 High Similarity NPC478248
0.8718 High Similarity NPC228357
0.8718 High Similarity NPC471405
0.8707 High Similarity NPC220942
0.8701 High Similarity NPC36130
0.8701 High Similarity NPC134905
0.8701 High Similarity NPC478268
0.8699 High Similarity NPC37468
0.8699 High Similarity NPC186418
0.8693 High Similarity NPC158635
0.8693 High Similarity NPC229882
0.8684 High Similarity NPC192763
0.8684 High Similarity NPC80732
0.8684 High Similarity NPC215095
0.8684 High Similarity NPC3460
0.8684 High Similarity NPC261122
0.8684 High Similarity NPC199311
0.8684 High Similarity NPC300262
0.8684 High Similarity NPC201148
0.8684 High Similarity NPC210611
0.8684 High Similarity NPC28651
0.8679 High Similarity NPC145847
0.8675 High Similarity NPC476865
0.8671 High Similarity NPC478265
0.8671 High Similarity NPC138993
0.8667 High Similarity NPC63304
0.8667 High Similarity NPC473281
0.8667 High Similarity NPC77922
0.8662 High Similarity NPC187205
0.8662 High Similarity NPC472860
0.8662 High Similarity NPC133984
0.8654 High Similarity NPC10205
0.8645 High Similarity NPC246893
0.8645 High Similarity NPC157898
0.8627 High Similarity NPC96599
0.8627 High Similarity NPC283839
0.8627 High Similarity NPC90896
0.8627 High Similarity NPC111785
0.8625 High Similarity NPC109990
0.8618 High Similarity NPC232992
0.8611 High Similarity NPC254819
0.8609 High Similarity NPC476864
0.8609 High Similarity NPC476869
0.8609 High Similarity NPC476866
0.8609 High Similarity NPC476868
0.8608 High Similarity NPC289811
0.8608 High Similarity NPC160780
0.8599 High Similarity NPC478055
0.8591 High Similarity NPC186406
0.8581 High Similarity NPC289438
0.8571 High Similarity NPC470934
0.8571 High Similarity NPC188393
0.8571 High Similarity NPC117346
0.8571 High Similarity NPC240592
0.8571 High Similarity NPC205054
0.8571 High Similarity NPC470572
0.8562 High Similarity NPC41009
0.8562 High Similarity NPC471883
0.8562 High Similarity NPC23677
0.8553 High Similarity NPC239966
0.8553 High Similarity NPC199928
0.8553 High Similarity NPC473867
0.8553 High Similarity NPC203020
0.8552 High Similarity NPC473285
0.8544 High Similarity NPC1913
0.8543 High Similarity NPC232228
0.8543 High Similarity NPC476867
0.8537 High Similarity NPC470685
0.8535 High Similarity NPC131532
0.8526 High Similarity NPC105827
0.8526 High Similarity NPC137813
0.8526 High Similarity NPC310661
0.8516 High Similarity NPC7145
0.8516 High Similarity NPC125823
0.8516 High Similarity NPC85192
0.8516 High Similarity NPC143480
0.8509 High Similarity NPC100420
0.8506 High Similarity NPC471062
0.8506 High Similarity NPC106138
0.8506 High Similarity NPC476386
0.8506 High Similarity NPC306890
0.8506 High Similarity NPC259347
0.8506 High Similarity NPC94871
0.8506 High Similarity NPC476398
0.8506 High Similarity NPC470933
0.8506 High Similarity NPC473427
0.8503 High Similarity NPC476870
0.8503 High Similarity NPC477301
0.85 High Similarity NPC472859
0.85 High Similarity NPC25389
0.85 High Similarity NPC311803
0.8497 Intermediate Similarity NPC18789
0.8493 Intermediate Similarity NPC254398
0.8491 Intermediate Similarity NPC469654
0.8485 Intermediate Similarity NPC316539
0.8483 Intermediate Similarity NPC219677
0.8481 Intermediate Similarity NPC11411
0.8481 Intermediate Similarity NPC478266
0.8477 Intermediate Similarity NPC88754
0.8477 Intermediate Similarity NPC263397
0.8477 Intermediate Similarity NPC237872
0.8477 Intermediate Similarity NPC302286
0.8477 Intermediate Similarity NPC116104
0.8472 Intermediate Similarity NPC229784
0.8472 Intermediate Similarity NPC307110
0.8472 Intermediate Similarity NPC477294
0.8472 Intermediate Similarity NPC477293
0.8471 Intermediate Similarity NPC472128
0.8471 Intermediate Similarity NPC472127
0.8467 Intermediate Similarity NPC472711
0.8462 Intermediate Similarity NPC472612
0.8462 Intermediate Similarity NPC289967
0.8462 Intermediate Similarity NPC472611
0.8457 Intermediate Similarity NPC472130
0.8457 Intermediate Similarity NPC472131
0.8457 Intermediate Similarity NPC475738
0.8452 Intermediate Similarity NPC257970
0.8452 Intermediate Similarity NPC476871
0.8452 Intermediate Similarity NPC470927
0.8452 Intermediate Similarity NPC227980
0.8447 Intermediate Similarity NPC33298
0.8447 Intermediate Similarity NPC285108
0.8447 Intermediate Similarity NPC246024
0.8442 Intermediate Similarity NPC478237
0.8438 Intermediate Similarity NPC44507
0.8438 Intermediate Similarity NPC166277
0.8438 Intermediate Similarity NPC119125
0.8435 Intermediate Similarity NPC169398
0.8435 Intermediate Similarity NPC35731
0.8431 Intermediate Similarity NPC474268
0.8431 Intermediate Similarity NPC474234
0.8431 Intermediate Similarity NPC475539
0.8431 Intermediate Similarity NPC473147
0.8431 Intermediate Similarity NPC143246
0.8431 Intermediate Similarity NPC119773
0.8431 Intermediate Similarity NPC98356
0.8428 Intermediate Similarity NPC40920
0.8428 Intermediate Similarity NPC104275

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC203664 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8827 High Similarity NPD7685 Pre-registration
0.8333 Intermediate Similarity NPD7266 Discontinued
0.8269 Intermediate Similarity NPD1653 Approved
0.8176 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD7228 Approved
0.8037 Intermediate Similarity NPD6234 Discontinued
0.8024 Intermediate Similarity NPD3818 Discontinued
0.7976 Intermediate Similarity NPD7054 Approved
0.795 Intermediate Similarity NPD37 Approved
0.7929 Intermediate Similarity NPD7472 Approved
0.7914 Intermediate Similarity NPD4967 Phase 2
0.7914 Intermediate Similarity NPD4966 Approved
0.7914 Intermediate Similarity NPD4965 Approved
0.7898 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD6190 Approved
0.7831 Intermediate Similarity NPD7199 Phase 2
0.7824 Intermediate Similarity NPD7074 Phase 3
0.7733 Intermediate Similarity NPD7251 Discontinued
0.7697 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD7808 Phase 3
0.7674 Intermediate Similarity NPD6797 Phase 2
0.7633 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD7240 Approved
0.7619 Intermediate Similarity NPD8127 Discontinued
0.7568 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD230 Phase 1
0.7531 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD9494 Approved
0.743 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD1934 Approved
0.7386 Intermediate Similarity NPD3027 Phase 3
0.7375 Intermediate Similarity NPD4628 Phase 3
0.7372 Intermediate Similarity NPD6653 Approved
0.7365 Intermediate Similarity NPD8455 Phase 2
0.7365 Intermediate Similarity NPD2801 Approved
0.7347 Intermediate Similarity NPD1357 Approved
0.7345 Intermediate Similarity NPD8313 Approved
0.7345 Intermediate Similarity NPD8312 Approved
0.733 Intermediate Similarity NPD6559 Discontinued
0.7321 Intermediate Similarity NPD3817 Phase 2
0.7315 Intermediate Similarity NPD3705 Approved
0.7312 Intermediate Similarity NPD6674 Discontinued
0.7297 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD6166 Phase 2
0.7283 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD3882 Suspended
0.7273 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD1465 Phase 2
0.7262 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD5844 Phase 1
0.7253 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD7473 Discontinued
0.7234 Intermediate Similarity NPD7680 Approved
0.7219 Intermediate Similarity NPD5353 Approved
0.7207 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD1091 Approved
0.7186 Intermediate Similarity NPD4380 Phase 2
0.7186 Intermediate Similarity NPD7028 Phase 2
0.7168 Intermediate Similarity NPD6232 Discontinued
0.716 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD8166 Discontinued
0.716 Intermediate Similarity NPD4110 Phase 3
0.7135 Intermediate Similarity NPD7075 Discontinued
0.7134 Intermediate Similarity NPD1613 Approved
0.7134 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD7097 Phase 1
0.7095 Intermediate Similarity NPD5536 Phase 2
0.7089 Intermediate Similarity NPD6355 Discontinued
0.7089 Intermediate Similarity NPD447 Suspended
0.7078 Intermediate Similarity NPD5647 Approved
0.7055 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD5494 Approved
0.7041 Intermediate Similarity NPD6386 Approved
0.7041 Intermediate Similarity NPD6385 Approved
0.7037 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD1511 Approved
0.7025 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD3620 Phase 2
0.7024 Intermediate Similarity NPD7458 Discontinued
0.7018 Intermediate Similarity NPD5402 Approved
0.7006 Intermediate Similarity NPD3751 Discontinued
0.6988 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6981 Remote Similarity NPD1933 Approved
0.6975 Remote Similarity NPD5762 Approved
0.6975 Remote Similarity NPD5763 Approved
0.6962 Remote Similarity NPD6233 Phase 2
0.6959 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6959 Remote Similarity NPD7819 Suspended
0.6957 Remote Similarity NPD7033 Discontinued
0.6946 Remote Similarity NPD1512 Approved
0.6933 Remote Similarity NPD9545 Approved
0.6928 Remote Similarity NPD4357 Discontinued
0.6923 Remote Similarity NPD2861 Phase 2
0.6918 Remote Similarity NPD228 Approved
0.6918 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6901 Remote Similarity NPD6801 Discontinued
0.6899 Remote Similarity NPD6859 Clinical (unspecified phase)
0.689 Remote Similarity NPD1652 Phase 2
0.6882 Remote Similarity NPD7296 Approved
0.6879 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7435 Discontinued
0.6875 Remote Similarity NPD3787 Discontinued
0.6875 Remote Similarity NPD1358 Approved
0.6871 Remote Similarity NPD6004 Phase 3
0.6871 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6871 Remote Similarity NPD6002 Phase 3
0.6871 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6871 Remote Similarity NPD6005 Phase 3
0.6848 Remote Similarity NPD8434 Phase 2
0.6845 Remote Similarity NPD6273 Approved
0.6835 Remote Similarity NPD7095 Approved
0.6829 Remote Similarity NPD2424 Discontinued
0.6818 Remote Similarity NPD1608 Approved
0.6818 Remote Similarity NPD9269 Phase 2
0.6815 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6813 Remote Similarity NPD4060 Phase 1
0.681 Remote Similarity NPD2935 Discontinued
0.6806 Remote Similarity NPD3134 Approved
0.6805 Remote Similarity NPD5403 Approved
0.6795 Remote Similarity NPD2797 Approved
0.6795 Remote Similarity NPD6362 Approved
0.6792 Remote Similarity NPD3268 Approved
0.6792 Remote Similarity NPD3764 Approved
0.6792 Remote Similarity NPD6798 Discontinued
0.6788 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6786 Remote Similarity NPD2532 Approved
0.6786 Remote Similarity NPD8151 Discontinued
0.6786 Remote Similarity NPD2534 Approved
0.6786 Remote Similarity NPD2533 Approved
0.6784 Remote Similarity NPD7930 Approved
0.677 Remote Similarity NPD5123 Clinical (unspecified phase)
0.677 Remote Similarity NPD5124 Phase 1
0.6765 Remote Similarity NPD3687 Approved
0.6765 Remote Similarity NPD3686 Approved
0.6763 Remote Similarity NPD2978 Approved
0.6763 Remote Similarity NPD2977 Approved
0.6758 Remote Similarity NPD7038 Approved
0.6758 Remote Similarity NPD7039 Approved
0.6747 Remote Similarity NPD3750 Approved
0.6742 Remote Similarity NPD5242 Approved
0.6732 Remote Similarity NPD1778 Approved
0.6731 Remote Similarity NPD3225 Approved
0.6726 Remote Similarity NPD6799 Approved
0.6725 Remote Similarity NPD3455 Phase 2
0.6724 Remote Similarity NPD8443 Clinical (unspecified phase)
0.672 Remote Similarity NPD6842 Approved
0.672 Remote Similarity NPD6841 Approved
0.672 Remote Similarity NPD6843 Phase 3
0.6719 Remote Similarity NPD6779 Approved
0.6719 Remote Similarity NPD6780 Approved
0.6719 Remote Similarity NPD6781 Approved
0.6719 Remote Similarity NPD6776 Approved
0.6719 Remote Similarity NPD6782 Approved
0.6719 Remote Similarity NPD6777 Approved
0.6719 Remote Similarity NPD6778 Approved
0.6718 Remote Similarity NPD7999 Approved
0.6711 Remote Similarity NPD5283 Phase 1
0.6709 Remote Similarity NPD5736 Approved
0.6708 Remote Similarity NPD4140 Approved
0.6707 Remote Similarity NPD2438 Suspended
0.6687 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6686 Remote Similarity NPD5401 Approved
0.6683 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5585 Approved
0.6667 Remote Similarity NPD2983 Phase 2
0.6667 Remote Similarity NPD2982 Phase 2
0.6667 Remote Similarity NPD7874 Approved
0.6667 Remote Similarity NPD5058 Phase 3
0.6667 Remote Similarity NPD8150 Discontinued
0.6667 Remote Similarity NPD4340 Discontinued
0.6667 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6649 Remote Similarity NPD6823 Phase 2
0.6647 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6647 Remote Similarity NPD7411 Suspended
0.6647 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6646 Remote Similarity NPD1510 Phase 2
0.6646 Remote Similarity NPD6663 Approved
0.6646 Remote Similarity NPD4062 Phase 3
0.6645 Remote Similarity NPD422 Phase 1
0.6633 Remote Similarity NPD7783 Phase 2
0.6633 Remote Similarity NPD7782 Clinical (unspecified phase)
0.663 Remote Similarity NPD7549 Discontinued
0.6628 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6628 Remote Similarity NPD3226 Approved
0.6627 Remote Similarity NPD1549 Phase 2
0.6626 Remote Similarity NPD2492 Phase 1
0.6623 Remote Similarity NPD7157 Approved
0.6623 Remote Similarity NPD17 Approved
0.6615 Remote Similarity NPD7696 Phase 3
0.6615 Remote Similarity NPD7698 Approved
0.6615 Remote Similarity NPD7697 Approved
0.661 Remote Similarity NPD919 Approved
0.6606 Remote Similarity NPD6100 Approved
0.6606 Remote Similarity NPD6099 Approved
0.6603 Remote Similarity NPD2981 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data